Clinical Trials

91 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT04888741 2023-09-28

MoTD

LymphoidMyeloidOther hematologic neoplasmPlasma cell

400 enrolled

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

NCT01004640 2023-09-14

Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial

60 enrolled

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02338479 2023-02-08

Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

340 enrolled

Anemia, Refractory, with Excess of Blasts, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT03709017 2022-12-07

Iclusig PMS in CML or Ph+ALL Patients

50 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT04155411 2022-07-27

Dose Reduced Dasatinib (70 mg Daily) as First-line Treatment for Newly Diagnosed CML-CP

Phase 4 Unknown

65 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT05154474 2022-05-03

SPACE2

BreastClassical hematologyGastrointestinalGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

150 enrolled

Anemia, Refractory, with Excess of Blasts, Breast Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Sarcopenia

NCT02602314 2022-01-20

SUSTRENIM

Phase 4 Unknown

450 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01752062 2022-01-05

CML1012

148 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01761890 2022-01-05

CML1113

147 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT05092048 2021-10-25

Case-Only

10,000 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT05080829 2021-10-18

Myeloid Mutations Register in R/R CML

Phase NA Unknown

29 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT04991532 2021-08-05

Dasatinib Down-regulates the Expression of PD-1 and Enhances Killing pH + Leukemia Stem Cells

324 enrolled

Phase EARLY_PHASE1 Unknown

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT03795779 2021-05-19

CLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies

20 enrolled

Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT04818619 2021-03-29

TIGIT in Patients With Chronic Myeloid Leukemia

65 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT04709731 2021-02-03

CarPAs

50 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02172365 2020-11-02

Allogeneic SCT for CML, TKI Failure After TKI Failure

350 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT04578847 2020-10-08

READIT

100 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02381379 2020-09-14

MSIT

Phase 3 Unknown

118 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02885766 2020-02-17

Study to Evaluate Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy of PF-114 for Oral Administration in Adults With Ph+ Chronic Myeloid Leukemia, Which is Resistant to the 2-nd Generation Bcr-Abl Inhibitors or Has T315I Mutation in the BCR-ABL Gene

Phase 1/2 Unknown

65 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT01046305 2020-01-07

Symptom Burden in Chronic Myeloid Leukemia (CML)

210 enrolled

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02268370 2019-11-29

TRAD

131 enrolled

Phase EARLY_PHASE1 Unknown

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT04156256 2019-11-12

CD123-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies

20 enrolled